Participation in Forum on February 26, 2025
Dear @Tarusenga Munyanyi,In short, it is crucial to monitor the evolution of the virus and compare with the existing vaccine options. At Kemin Biologics we have a continuous monitoring programme and have continuous updates of the vaccine seed according to virus evolution. In addition, we offer vaccines with multiple viral clades included to provide a buffer for virus reassortment through cross-pro ...
Video published on February 4, 2025
Matias Jansen (Kemin Biologics) shares insights on avian influenza and hepatitis threats in this Engormix interview during IPPE 2025 in Atlanta, USA.
This member had joined Engormix
January 10, 2025